|
2025
|
P/S
|
Pharmaceuticals, namely, protein kinase inhibitors |
|
|
P/S
|
Pharmaceutical preparations for the treatment and prevention of cancer |
|
2024
|
Invention
|
Pharmaceutical compositions.
The present invention relates to the field of methods for providing... |
|
|
Invention
|
Pharmaceutical compositions comprising nilotinib. Disclosed herein is a composition comprising: a... |
|
|
Invention
|
Pharmaceutical compositions. The present invention relates to the field of methods for providing ... |
|
2023
|
Invention
|
Fast dissolving pharmaceutical compositions.
The present disclosure relates to the field of phar... |
|
2022
|
Invention
|
Rapidly disintegrating solid oral dosage forms containing dasatinib. The instant application rela... |
|
|
Invention
|
Fast dissolving pharmaceutical compositions. The present disclosure relates to the field of pharm... |
|
|
Invention
|
Fast dissolving pharmaceutical compositions of dasatinib. The present disclosure relates to the f... |
|
2013
|
Invention
|
Pharmaceutical composition comprising stable, amorphous, hybrid nanoparticles of at least one pro... |
